Ovarian cancer screening: Development of the risk of ovarian cancer algorithm (ROCA) and ROCA screening trials

International Journal of Gynecological Cancer

Volumn 22, Issue SUPPL. 1, 2012, Pages

  Skates, Steven J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Early detection; Longitudinal CA125; Ovarian cancer; ROCA

Indexed keywords

CA 125 ANTIGEN;

CALCULATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CONFERENCE PAPER; HUMAN; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK OF OVARIAN CANCER ALGORITHM; SALPINGOOOPHORECTOMY; STATISTICAL ANALYSIS; TRANSVAGINAL ECHOGRAPHY;

ADULT; ALGORITHMS; CA-125 ANTIGEN; CLINICAL TRIALS AS TOPIC; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; OVARIAN NEOPLASMS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84863693148     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318256488a     Document Type: Conference Paper

References (9)

1. Jacobs I, Davies AP, Bridges J, et al. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. BMJ. 1993;306:1030-1034. (Pubitemid 23105960)
2. Einhorn N, Sjövall K, Knapp RC, et al. Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol. 1992;80:14-18.
3. Jacobs I, Bast RC Jr. The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod. 1989;4:1-12. (Pubitemid 19069900)
4. Skates SJ, Xu FJ, Yu YH, et al. Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer. 1995;76:2004-2010.
5. Skates SJ, Pauler DK, Jacobs IJ. Screening based on the risk of cancer calculation fromBayesian hierarchical change-point and mixture models of longitudinal markers. J Am Stat Assoc. 2001;96:429-439.
6. Menon U, Skates SJ, Lewis S, et al. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncol. 2005;23:7919-7926. (Pubitemid 46657391)
7. Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10:327-340.
8. Skates SJ, Mai P, Horick NK, et al. Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. Cancer Prev Res (Phila). 2011;4:1401-1408.
9. Greene MH, Piedmonte M, Alberts D, et al. A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study. Cancer Epidemiol Biomarkers Prev. 2008;17:594-604. (Pubitemid 351469209)